SARTORIUS STEDIM BIOTECH
Sartorius Stedim Biotech S.A. - 13781 Aubagne France
ANNUAL REPORTOF THE LIQUIDITY CONTRACTWITH THE STOCKBROKER COMPANY GILBERT DUPONT
Aubagne, France | January 4, 2017
Under the liquidity contract concluded between Sartorius Stedim Biotech S.A. and the stockbroker Gilbert Dupont, the following assets appeared on the liquidity account at December 29, 2017:
- Number of shares: 2,178 - Liquidity account cash balance: EUR 475,474.10
For information, the following assets appeared on the half-year report of the liquidity contractof
- Number of shares: 0 - Liquidity account cash balance: EUR 0
It is also reminded that at the time of the implementation of the contract, November 6, 2017, the following assets were allocated to the liquidity account:
- EUR600,000.00
A profile of Sartorius Stedim Biotech Sartorius Stedim Biotech is a leading international supplier of products and services that enable the biopharmaceutical industry to develop and manufacture drugs safely and efficiently. As a total solutions provider, Sartorius Stedim Biotech offers a portfolio covering nearly all steps of biopharmaceutical manufacture. The company focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Headquartered in Aubagne, France, Sartorius Stedim Biotech is quoted on the Eurolist of Euronext Paris. With its own manufacturing and R&D sites in Europe, North America and Asia and an international network of sales companies, Sartorius Stedim Biotech has a global reach. In 2016, the company employed approx. 4,700 people, and earned sales revenue of 1,051.6 million euros. _________________________________________________________________________________________
Contact Mirko Koch Investor Relations mirko.koch@sartorius.com
Sartorius Stedim Biotech SA Z.I. Les Paluds Avenue de Jouques, CS 91051 13781 Aubagne Cedex, France Phone: +33.(0)4.42.84.56.00 Fax: +33.(0)4.42.84.56.19 www.sartorius-stedim.com
Regulatory filing PDF file Document title: ANNUAL REPORT OF THE LIQUIDITY CONTRACT WITH THE STOCKBROKER COMPANY GILBERT DUPONT Document: http://n.eqs.com/c/fncls.ssp?u=STMEKOETOC |
| Language: | English |
| Company: | Sartorius Stedim Biotech SA |
| Avenue de Jouques | |
| 13781 Aubagne | |
| France | |
| Phone: | +33 44 284 5600 |
| E-mail: | info@sartorius-stedim.com |
| Internet: | www.sartorius-stedim.com |
| ISIN: | FR0013154002 |
| Euronext Ticker: | DIM |
| AMF Category: | Information relating to the liquidity contract |
| End of Announcement | EQS News Service |
642891 04-Jan-2018 CET/CEST
